Literature DB >> 2932538

Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.

A J Thompson, J Brazil, E A Martin, M Hutchinson, C A Whelan, C Feighery.   

Abstract

This study demonstrates a significant reduction in the number of both total T cells and suppressor T cells identified by monoclonal antibodies in multiple sclerosis patients in acute relapse but not in those in remission. The reduction in the number of suppressor T cells was shown by all three monoclonal antibodies used but was most clearly demonstrated using Leu 2a rather than either OKT 8 or OKT 5. These findings suggest that the choice of monoclonal antibody used in a study of suppressor T cell numbers will influence the results and may help explain the lack of agreement in previous studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932538      PMCID: PMC1028550          DOI: 10.1136/jnnp.48.10.1062

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  T and B lymphocytes in multiple sclerosis.

Authors:  R P Lisak; A I Levinson; B Zweiman; N I Abdou
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

2.  Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes.

Authors:  E L Reinherz; R E Hussey; K Fitzgerald; P Snow; C Terhorst; S F Schlossman
Journal:  Nature       Date:  1981-11-12       Impact factor: 49.962

3.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

4.  T suppressor (TG) lymphocytes fluctuate in parallel with changes in the clinical course of patients with multiple sclerosis.

Authors:  J R Huddlestone; M B Oldstone
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

5.  Enumeration of human lymphocyte subpopulations by immunofluorescence: a comparative study using automated flow microfluorometry and fluorescence microscopy.

Authors:  A Landay; G L Gartland; T Abo; M D Cooper
Journal:  J Immunol Methods       Date:  1983-03-25       Impact factor: 2.303

6.  Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.

Authors:  E L Reinherz; H L Weiner; S L Hauser; J A Cohen; J A Distaso; S F Schlossman
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

7.  Lymphocyte subpopulations in patients with multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

8.  Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period.

Authors:  S L Hauser; E L Reinherz; C J Hoban; S F Schlossman; H L Weiner
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

9.  Deficit of suppressor T cells in active multiple sclerosis.

Authors:  M A Bach; F Phan-Dinh-Tuy; E Tournier; L Chatenoud; J F Bach; C Martin; J D Degos
Journal:  Lancet       Date:  1980-12-06       Impact factor: 79.321

10.  Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man.

Authors:  J A Ledbetter; R L Evans; M Lipinski; C Cunningham-Rundles; R A Good; L A Herzenberg
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  3 in total

1.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

2.  Factors influencing circulating OKT8 cell phenotypes in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; J Dyas; J A Munro; K I Welsh; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

Review 3.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.